Ankit Mahadevia, See Remarks at Spero Therapeutics, Inc. (SPRO), sold 3,076 shares at $17.62 ($54K) on 2018-07-05, disclosed to the SEC on 2018-07-06.
Open-market sale of $54k SPRO by See Remarks. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| SPRO | SELL | 2024-08-29 | $8K | — | Filing → |
| SPRO | SELL | 2024-02-05 | $175K | — | Filing → |
| SPRO | SELL | 2023-08-30 | $11K | — | Filing → |